Tech Company Financing Transactions
Grid Therapeutics Funding Round
Longview International and private investors joined a Series A funding round for Grid Therapeutics. The round closed on 9/15/2017.
Transaction Overview
Company Name
Announced On
9/15/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Longview International (Lead Investor) (Jianli Wang)
Proceeds Purpose
Grid will use the proceeds from the financing to fund the antibody production and Phase 1 clinical trial of its lead candidate for the treatment of solid tumors.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Durham, NC 27517
USA
Durham, NC 27517
USA
Phone
Website
Email Address
Overview
Grid Therapeutics is an emerging biotechnology company located in Durham, North Carolina. Grid's research and development efforts are in the area of cancer therapeutics, applying an innovative platform to develop human derived antibodies against novel targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edward Patz
Chief Operating Officer
Thomas Patz
VP - Bus. Development
Scott Lyman
Browse more venture capital transactions:
Prev: 9/15/2017: Patreon venture capital transaction
Next: 9/15/2017: Federated Wireless venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs